/

Empresas

Bo

No verificado

Boehringer Ingelheim

Sobre qué escribimos

EmpresasFarmacéuticaIndustriaMedicina Salud BienestarPublicidad/Marketing/Medios de comunicación/Comunicación

4 Comunicados de prensa

Ver todos los comunicados de prensa

03/09/2025

Boehringer Ingelheim Launches Swine Vaccine With Advanced Protection Against Porcine Circovirus Type 2 in the United States

Fuente

Boehringer Ingelheim

Editor

1.00

0

Press Release cover image

22/11/2024

Farmacéutica

Sanidad

Economía

Start-up

Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs

Fuente

Boehringer Ingelheim

Editor

1.00

0

07/10/2024

Farmacéutica

Medicina Salud Bienestar

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Fuente

Boehringer Ingelheim

Editor

1.00

0

16/09/2024

Farmacéutica

Medicina Salud Bienestar

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study

Fuente

Boehringer Ingelheim

Editor

1.00

0

Seguidores

0

Compatibilidad

0